Bilix
Yongsin · Founded 2018
About Bilix
Bilix produces anti-inflammatory and cancer therapy drugs for inflammatory diseases.
Company Facts
- Founded: 2018
- Legal name: Bilix, Co., Ltd.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $14.2M
- Funding stage: Early Stage Venture
- Last round: Series Unknown (Jan 2019)
- Website: bilix.com
- Phone: +82 31 212 0961
Social Profiles
Canonical: https://fsome.com/organization/bilix-8440821 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.